TFEB and breast carcinoma: Further investigations will help to clarify whether the alteration of intracellular dynamics of TFEB represents a specific consequence of Tam treatment on luminal A breast cancer cells or rather a prototypical strategy of tumor cells to resist to anticancer treatments.